The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. - Wikidata - awgldk - TriplyDB

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.

http://www.wikidata.org/entity/Q43000313

about

Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis Pharmacological treatments for acute hepatitis C infection: a network meta-analysis New advances in hepatocellular carcinoma KASL clinical practice guidelines: management of hepatitis C Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Hepatocellular Carcinoma and Liver Transplantation: State of the Art Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?Liver fibrosis: mechanisms of immune-mediated liver injury 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Global epidemiology and burden of HCV infection and HCV-related disease.The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.An overview of triple infection with hepatitis B, C and D viruses.Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.The hepatitis C cascade of care: identifying priorities to improve clinical outcomes Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.Clinical outcomes of compensated and decompensated cirrhosis: A long term study.Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Complications of HIV disease and antiretroviral treatment.Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver disease A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm.HBV and HCV therapy.Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial.Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects.The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.

P2860

Q24186846-F12E5218-61BA-4F98-B776-568519388C14 Q24186859-3FD5446F-B501-45CB-B4E0-222972031016 Q26749329-B9E79441-2B35-466D-B6BA-C78B9402491E Q26752471-8007C274-DDD7-4E12-AF5C-65D73418A8BD Q26766707-A0C89834-16BC-47C8-B080-EC148575CCD4 Q26781798-7773BCBA-6DF1-4749-A3D8-AD21FE4EAC73 Q26830804-0264E013-CF15-48F3-9005-BB9EDCC0EC77 Q27027766-329FEE40-6AB8-43B2-A9C2-A8330AFFDB19 Q28392783-4EB28E8A-B58E-4B86-842D-3C72D8CF11CD Q28394414-6E9DE4D0-5DC2-4173-B78A-ED32E060A5C8 Q30240220-2BCB8F82-7539-4A3D-965C-CCCC6B7EC648 Q30250096-D27B8CC6-AD6C-4514-A1E5-87D88BE5A796 Q30485092-D19DB2C9-6892-4503-8334-3692DCAAF3E9 Q33576986-864F02B3-6C3B-447B-BF90-FEB3D2FEA54B Q33618516-34907405-9F2F-4151-99B1-1AE9870D08C4 Q33632459-5EF6FC99-21C3-4FC1-B440-FDCABC74E910 Q33668652-2FBAB90D-3BDE-4B42-B857-37338C0D7A29 Q33710740-2A5B4BA6-7B9C-4C18-A821-D650A2808AFD Q33948229-DCE1B718-0C4F-4DF4-8446-B9FD4827DA8C Q34061430-42D45EF5-D5DA-40FD-ACAB-7F7E9E1404C2 Q34098540-AF5D7745-2F43-47C9-9168-AC44A05F68A5 Q34233163-E63D9C4C-BE91-4587-8D3F-598676D1B833 Q34255487-015C7817-13EE-42A6-8E9B-1E4162C6DBA1 Q34547655-D7856EAF-E5F0-4CB1-B4FB-634D587CA479 Q34690368-D3375A00-A09F-489C-B941-1CD13621706D Q34735072-259284A5-7233-44C3-90AC-C5B7FC2A5CCC Q35004930-4C19CA2C-D9AD-4EB2-8C31-5D97D414CD5F Q35023155-0375F9DD-4EA7-4A40-9E99-E858A4F1502B Q35105799-1A7339B8-5CAB-4F60-ADE9-52DA2BD11AC0 Q35131882-7F88E513-F854-46C6-86DB-D84020E51BB4 Q35155028-1BE7B0AD-789A-43EB-A214-7CC5820FBE84 Q35171592-90041756-85B2-4245-8265-F084D37C06C3 Q35259824-79DDEBB9-9DC6-46F4-928F-21E9A07EA4A8 Q35273624-E2551B6A-E1D3-475E-A1CA-2AC3FE067302 Q35322521-0E95AD5F-BD1A-4C12-9FC5-2D7C2C140FC0 Q35514419-E3037040-13A8-49FA-A14E-E46EB0C62436 Q35572125-6172232B-F741-4B70-BFFF-F70CB0F856A8 Q35590977-42FD1F50-5C02-4CF2-8764-9AA92E602342 Q35609156-1DB57BB0-8E05-403A-90D4-7CD6880A1F8E Q35626757-D8C9D02E-0DCC-4FE5-939E-6E872CB9DD78

P2860

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.

http://www.wikidata.org/entity/Q43000313

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

The natural history of compens ...... cohort study of 214 patients.

@en

The natural history of compens ...... cohort study of 214 patients.

@nl

type

label

The natural history of compens ...... cohort study of 214 patients.

@en

The natural history of compens ...... cohort study of 214 patients.

@nl

prefLabel

The natural history of compens ...... cohort study of 214 patients.

@en

The natural history of compens ...... cohort study of 214 patients.

@nl

P1433

Q43000313-61A4AC41-E923-465F-A74D-F165F9F8B4A6

P1476

Q43000313-F06B24BE-E0DF-474D-8BEE-202E34910D7A

P2093

Q43000313-19B655CE-8F7F-443A-9915-7FF302EE4C98

Q43000313-1B61966E-A0C0-41E4-BFD7-52168EE54C12

Q43000313-4FEE1903-596B-4F1D-BBFB-99E8F5107C95

Q43000313-67198A67-35F6-4A3B-87A4-C0F9F0C576CA

Q43000313-76C7414A-E25B-4BF3-BC37-609B87DAC25D

Q43000313-99345079-DDDC-4BFA-BBD0-677F388BA799

Q43000313-AE313444-CC3A-48BB-80E0-DD4B02031930

Q43000313-C25B2EA0-AAFE-4804-94B0-665BDB4B3B06

P2860

Q43000313-62D38289-C2E5-438F-9CE0-68F4A6724FB7

Q43000313-74CCEE2F-621D-43A1-8578-886B821473FD

Q43000313-F1D62B04-F489-4F4B-AC13-493D79310F9B

P304

Q43000313-97A10216-85B3-4DB1-9503-52AE37331AF0

P31

Q43000313-86F1515E-87D8-4DCD-8365-6F83EF183AF3

P356

Q43000313-7744A54A-A7C7-49F1-BA96-BF55C4B2A847

P407

Q43000313-9DA1FAC2-4B04-4B4B-944E-495C6E11DABE

P433

Q43000313-986AC0A0-51F2-4A57-BBF4-59FB7A9E5F20

P478

Q43000313-E751E45D-3BFF-4CA1-B153-0316917DCC7B

P50

Q43000313-0F4BC98D-5DE0-449C-807C-60C12078630B

P577

Q43000313-D7CADC14-11BA-4FE7-9354-2E300FD3C102

P5875

Q43000313-F07F7EB2-E142-4C49-9330-AAE4300741EC

P698

Q43000313-25E95FEF-4AE6-42F6-B556-EA08691F9E08

P921

Q43000313-1A6ECA07-2966-4B57-A9D0-5819BA0689E7

Q43000313-4BC838EA-B9DD-4FC8-A4C1-FFA98FF0649C

P356

P1433

P1476

The natural history of compens ...... cohort study of 214 patients.

@en

P2093

Alberto Morabito

http://www.w3.org/2001/XMLSchema#string

Angelo Sangiovanni

http://www.w3.org/2001/XMLSchema#string

Ersilio Del Ninno

http://www.w3.org/2001/XMLSchema#string

Gian Maria Prati

http://www.w3.org/2001/XMLSchema#string

Guido Ronchi

http://www.w3.org/2001/XMLSchema#string

Massimo Colombo

http://www.w3.org/2001/XMLSchema#string

Pierangelo Fasani

http://www.w3.org/2001/XMLSchema#string

Raffaella Romeo

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Performance status assessment in cancer patients. An inter-observer variability study.

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.

P304

1303-1310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21176

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Matteo Angelo Manini

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7053965

http://www.w3.org/2001/XMLSchema#string

P698

16729298

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis